TABLE 2.
Patient Outcomes from a Mathematical Model of the Use of Fecal Transplantation to Prevent Clostridium difficile Infection and Recurrence in a Simulated 12-Bed Intensive Care Unit over a 1-Year Period
Scenario, treatment level, % | Median recurrence (25th percentile, 75th percentile) | Pa | Median incidence (25th percentile, 75th percentile) | Pa |
---|---|---|---|---|
Baseline, 0 | 2 (0, 6) | 0 (0, 1) | ||
After infection | ||||
20 | 1 (0, 4) | <.001 | 0 (0, 1) | .39 |
40 | 1 (0, 4) | 0 (0, 1) | ||
60 | 1 (0, 3) | 0 (0, 1) | ||
80 | 0 (0, 1) | 0 (0, 2) | ||
100 | 0 (0, 1) | 0 (0, 1) | ||
After receipt of high-risk medication (antibiotics) | ||||
Antibiotics | ||||
20 | 1 (0, 5) | .36 | 0 (0, 1) | .003 |
40 | 1 (0, 6) | 0 (0, 1) | ||
60 | 1 (0, 6) | 0 (0, 1) | ||
80 | 2 (0, 6) | 0 (0, 1) | ||
100 | 1 (0, 6) | 0 (0, 1) | ||
Antibiotics and PPIs | ||||
20 | 2 (0, 5.25) | .56 | 0 (0, 1) | .001 |
40 | 2 (0, 6) | 0 (0, 1) | ||
60 | 1 (0, 5) | 0 (0, 1) | ||
80 | 2 (0, 5) | 0 (0, 1) | ||
100 | 2 (0, 6) | 0 (0, 1) | ||
Combined | ||||
20 | 1 (0, 5) | <.001 | 0 (0, 1) | .02 |
40 | 1 (0, 4) | 0 (0, 1) | ||
60 | 1 (0, 3) | 0 (0, 1) | ||
80 | 0 (0, 2) | 0 (0, 1) | ||
100 | 0 (0, 1) | 0 (0, 1) |
NOTE. PPI, proton pump inhibitor.
Kruskal-Wallis 1-way analysis of variance test.